Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2022 / Articles / Sep / Catching Up With the Biologics Sector: Download Our eBook
Manufacture Bioprocessing - Single Use Systems Bioprocessing - Upstream & Downstream Biosimilars Biopharma

Catching Up With the Biologics Sector: Download Our eBook

Our free eBook showcases content on bioprocess scale up, biosimilars, primary packaging considerations, and more

09/30/2022 2 min read

Share

In this special eBook, we curate some of our top content covering the biopharma industry. 

According to Hunter Malanson from Thermo Fisher Scientific, “Scaling up the biomanufacturing processes established during early phase development is an exciting, challenging – and critical – step in the journey of a biologic. After all, the scaled-up process will be used throughout the product lifecycle – and it must be developed to be both cost-effective and sustainable in the long term.” But when you’re scaling up – don’t forget about your critical raw materials and securing supply! Malanson discusses the challenges in this area. 

We also have content on everyone’s favorite copycats: biosimilars. Experts from Bio-Rad Laboratories write about the importance of keeping biosimilar costs as low as possible, while Jeff Baldetti from Cardinal Health writes about the waves biosimilars are making in the US – and what else is needed to help these valuable products thrive. 

The eBook also includes an intriguing interview with Kristi Budzinski. Budzinski works for Roche Molecular Systems and is a member of the American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable (Pharma Roundtable). The Pharma Roundtable was formed to encourage innovation in green chemistry and engineering – and to help companies incorporate more sustainable approaches into their processes. 

Budzinski was recently the lead author on a study, conducted by the Pharma Roundtable, examining the life cycle assessment of single use technologies in biopharma manufacturing. We speak with her about the paper, the Pharma Roundtable’s efforts to encourage the uptake of greener manufacturing, and her views on how the industry can improve sustainability in both small molecule and biopharmaceutical manufacturing – and we hope you will find it enlightening and inspirational. 

This is just a snapshot of the exciting content in our eBook. We also talk about extractables and leachables, microbial biomanufacturing, The Medicine Maker’s collaboration with NIBRT, and we take a peek inside China’s biopharma industry. 

Download the PDF to read the content in full. 

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

AI Approach to Transdermal GLP-1s
Advanced Medicine Bioprocessing - Single Use Systems Bioprocessing - Upstream & Downstream Dosage Forms Contract Manufacturing Services Biosimilars Packaging Process Control Supply Chain Quality & Compliance
AI Approach to Transdermal GLP-1s

February 25, 2025

3 min read

How do you design, refine, and optimize novel GLP-1 drugs that could improve patient experiences? With a computer, of course.

ADCs: When Bioprocessing Becomes Toxic
Bioprocessing - Single Use Systems
ADCs: When Bioprocessing Becomes Toxic

January 31, 2025

3 min read

Doing more to ease the challenges of antibody drug conjugate manufacturing.

FDA or EMA Novel Drug Approvals 2024: Anagrams Edition
Advanced Medicine Bioprocessing - Single Use Systems Small Molecules Standards & Regulation
FDA or EMA Novel Drug Approvals 2024: Anagrams Edition

December 24, 2024

1 min read

So you know your small molecule from your AAV, but can you unscramble the names of these 2024 novel drug approvals?

Celebrating a Decade in Bioprocessing
Bioprocessing - Upstream & Downstream Bioprocessing - Single Use Systems
Celebrating a Decade in Bioprocessing

November 15, 2024

1 min read

The Medicine Maker is celebrating its 10-year anniversary! We look back on some of our top articles in biopharma and bioprocessing, from X-ray sterilization for single-use systems, to supply chains for sensitive products, to making biologic...

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.